Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-04-15

FDA Approved: LURASIDONE HYDROCHLORIDE — Supplemental Application (Lupin Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved Lupin Pharmaceuticals' supplemental application for lurasidone hydrochloride, enabling the generic to be marketed in the United States.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lurasidone hydrochloride (Lurasidone hydrochloride)

Snippet

SUPPL AP for LURASIDONE HYDROCHLORIDE (LURASIDONE HYDROCHLORIDE)